Market Tracker

06/24 5:16pm ET

Alkermes Plc (NASDAQ:ALKS)

42.28
Delayed Data
As of Jun 24
 -1.47 / -3.36%
Today’s Change
27.14
Today|||52-Week Range
80.71
-46.74%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close43.75
Today’s open41.57
Day’s range41.28 - 43.80
Volume1,577,516
Average volume (3 months)1,336,587
Market cap$6.4B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+18.76%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book4.85

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-2.75-4.68%
TAROTaro Pharmaceutical ...-4.56-3.18%
VRXValeant Pharmaceutic...-1.98-8.90%
SGENSeattle Genetics Inc-2.48-6.19%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts